International donors, including the Clinton Health Access Initiative, convinced Bayer to sell its Jadelle contraceptive implants, which work for up to five years, for $9 in "poor" countries.
Increasing access to contraception, which allows greater control over family planning, involves balancing several variables (cost, effectiveness in preventing pregnancy, likelihood of effective use, a million cultural considerations). The trade-off with implants is that there is some evidence that they increase H.I.V. contraction. Is a devil's bargain better than no bargain at all?
The New York Times: International Donors Get Bayer to Cut Price of Implantable Birth Control for the Poor
Increasing access to contraception, which allows greater control over family planning, involves balancing several variables (cost, effectiveness in preventing pregnancy, likelihood of effective use, a million cultural considerations). The trade-off with implants is that there is some evidence that they increase H.I.V. contraction. Is a devil's bargain better than no bargain at all?
The New York Times: International Donors Get Bayer to Cut Price of Implantable Birth Control for the Poor
Comments